Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and-9 in inflammatory synovial fluid: Effect of pyrophosphate and bisphosphonates

被引:17
|
作者
Makowski, GS
Ramsby, ML
机构
[1] Univ Connecticut, Ctr Hlth, Dept Lab Med, Sch Med, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Med, Sch Med, Farmington, CT 06030 USA
关键词
matrix metalloproteinases; gelatinases; synovial fluid; rheumatoid arthritis;
D O I
10.1016/j.cccn.2005.03.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The presence of matrix metalloprotemase-2 and -9 (MMP-2, MMP-9), gelatinase A and B. in synovial fluid is typical in inflammatory connective tissue diseases especially rheumatoid arthritis (RA), Because MMPs are synthesized as latent proforms, a pathophysiologic understanding of MMP regulation has focused on mechanisms of activation that remain to date largely unresolved. Methods: Synovial fluid was collected by aseptic aspiration from RA patients and incubated with and without physiologic levels of calcium and other modifiers (pyrophosphate, bisphosphonates. and the tissue inhibitors of MMP's, (TIMPS), under conditions that activate MMPs. MMP-2 and -9 were then characterized by substrate gel electrophoresis (gelatin zymography) to resolve both latent and activated 'partially proteolyzed' forms. Results: Gelatin zymography revealed that RA synovial fluid contained latent neutrophil MMP-9 (92, 130, 225 kDa) and fibroblast MMP-2 (72 kDa). A small amount of activated MMP-2 (64 kDa) was also noted, Incubation of synovial fluid without calcium resulted in MMP-9 activation to 87, 116, and 209 kDa forms, MMP-9 activation was, however, substantially delayed in the presence of physiologic calcium (2.5 mmol/l). MMP-2 did not demonstrate any appreciable activation with or without physiologic calcium. MMP-9 activation likely occurred via an autoactivation mechanism since it was susceptible to inhibition by the tissue inhibitor of MMP-9 (TIMP-1). Pyrophosphate and bisphosphonates (alendronate and risedronate) were ineffective in blocking synovial fluid MMP-9 autoactivation. Some early MMP-9 activation was noted with alendronate despite the presence of physiologic calcium. Discussion: Although RA synovial fluid contained abundant MMP-2 and MMP-9, only MMP-9 underwent autoactivation to lower molecular weight forms. MMP-9 was transiently stable in the presence of physiologic Calcium concentration, whereas autoactivation was more pronounced without exogenous calcium. The apparent lack of MMP-2 autoactivation with or without calcium, likely resulted from the coexistence of its bound endogenous inhibitor, TIMP-2. The role of differential autoactivation of MMPs activity in inflammatory arthritic disease is discussed. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:182 / 191
页数:10
相关论文
共 50 条
  • [1] Autoactivation profiles of matrix metalloproteinase-2 and-9 in inflammatory synovial fluid
    Makowski, GS
    Ramsby, ML
    [J]. CLINICAL CHEMISTRY, 2005, 51 : A87 - A87
  • [2] Synovial fluid matrix metalloproteinase-2 and-9 activities in dogs suffering from joint disorders
    Murakami, Kohei
    Maeda, Shingo
    Yonezawa, Tomohiro
    Matsuki, Naoaki
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 2016, 78 (06): : 1051 - 1054
  • [3] Change Profiles in Matrix Metalloproteinase-2 and-9 in Induced Endometriosis in Mice
    Chen, Qionghua
    Qiu, Naxuan
    Pu, Demin
    Zhou, Yumin
    Li, Tian
    Yang, Hongyi
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2010, 30 (02) : 188 - 192
  • [4] Change Profiles in Matrix Metalloproteinase-2 and-9 in Induced Endometriosis in Mice
    陈琼华
    邱娜璇
    濮德敏
    周玉明
    李天
    杨宏毅
    [J]. Current Medical Science, 2010, 30 (02) : 188 - 192
  • [5] Expression of matrix metalloproteinase-2 and-9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement
    Tanaka, A
    Kumagai, S
    Kawashiri, S
    Takatsuka, S
    Nakagawa, K
    Yamamoto, E
    Matsumoto, N
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2001, 30 (01) : 59 - 64
  • [6] EVALUATION OF MATRIX METALLOPROTEINASE-2 AND-9 IN THE CEREBROSPINAL FLUID OF DOGS WITH INTRACRANIAL DISEASE
    Boozer, L. B.
    Mariani, C. L.
    Campbell, J.
    Dillard, S.
    Early, P. J.
    Gallagher, R.
    MacKillop, E.
    Munana, K. R.
    Niman, Z. E.
    Olby, N. J.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (03) : 741 - 741
  • [7] Characterization of matrix metalloproteinase-2 and-9 in cerebrospinal fluid of clinically normal dogs
    Bergman, RL
    Inzana, KD
    Inzana, TJ
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (10) : 1359 - 1362
  • [8] Evaluation of matrix metalloproteinase-2 and-9 in the cerebrospinal fluid of dogs with intracranial tumors
    Mariani, Christopher L.
    Boozer, Lindsay B.
    Braxton, Alicia M.
    Platt, Simon R.
    Vernau, Karen M.
    McDonnell, John J.
    Guevar, Julien
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2013, 74 (01) : 122 - 129
  • [9] Matrix metalloproteinase-2 and-9 levels in obese patients
    Derosa, G.
    Ferrari, I.
    D'Angelo, A.
    Tinelli, C.
    Salvadeo, S. A. T.
    Ciccarelli, L.
    Piccinni, M. N.
    Gravina, A.
    Ramondetti, F.
    Maffioli, P.
    Cicero, A. F. G.
    [J]. ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2008, 15 (04): : 219 - 224
  • [10] Matrix metalloproteinase-2 and-9 are activated in joint diseases
    Clegg, PD
    Carter, SD
    [J]. EQUINE VETERINARY JOURNAL, 1999, 31 (04) : 324 - 330